SPRINGWORKS THERAPEUTICS, INC.

Insiders SpringWorks Therapeutics, Inc.

Equities

SWTX

US85205L1070

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
46.45 ^USD	+2.02%		+8.30%	+27.26%

Mar. 12	Transcript : SpringWorks Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:00 AM
Mar. 06	JPMorgan Adjusts Price Target on SpringWorks Therapeutics to $75 From $74, Keeps Overweight Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Springworks Therapeutics Insider Sold Shares Worth $1,160,362, According to a Recent SEC Filing	Feb. 06	MT
SpringWorks Therapeutics, Inc. Announces Resignation of L. Mary Smith as Chief Development Officer	Feb. 02	CI
SpringWorks Therapeutics, Inc. Appoints Tai-An Lin as Chief Scientific Officer	23-09-11	CI
SpringWorks Therapeutics, Inc. Announces Resignation of Jeffrey Schwartz as Member of the Board and as Member of the Compensation Committee and the Audit Committee	23-09-01	CI
Insider Sell: Springworks Therapeutics	23-03-20	MT
SpringWorks Therapeutics, Inc. Announces Resignation of Michael Burgess as the Head of Research and Development	22-09-16	CI
SpringWorks Therapeutics, Inc. Appoints Carlos Albán to Board of Directors	22-07-15	CI
SpringWorks Therapeutics, Inc. Announces Resignation of Stephen Squinto as Member of the Board	22-07-15	CI
Insider Sell: Springworks Therapeutics	21-10-20	MT
SpringWorks Therapeutics, Inc. Appoints James Cassidy as Chief Medical Officer	21-07-27	CI
SpringWorks Therapeutics, Inc. Announces Executive Changes	21-05-10	CI
SpringWorks Therapeutics Appoints Bhavesh Ashar as Chief Commercial Officer	21-03-22	CI
SpringWorks Therapeutics Announces Executive Changes	20-12-15	CI
SpringWorks Therapeutics, Inc. Appoints Julie Hambleton to its Board of Directors	20-05-26	CI
Springworks Therapeutics Appoints Alan Fuhrman to Board of Directors and as Chair of Audit Committee	19-08-30	CI
SpringWorks Therapeutics, Inc. Appoints Francis Perier, Jr. as Chief Financial Officer	19-08-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer